Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings

Murphy SM, Dweik D, McPherson S, Roll JM. Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings. Am J Drug Alcohol Abuse. 2015;41(1):88-92.

Publication Type:

Journal Article

Authors:

Murphy, Sean M.; Dweik, Dana; McPherson, Sterling; Roll, John M.

Source:

Am J Drug Alcohol Abuse, Volume 41, Issue 1, p.88-92 (2015)

Keywords:

Adolescent, Adult, Buprenorphine, Drug Administration Schedule, Female, Hepacivirus, Hepatitis Antibodies, Hepatitis C, Humans, Longitudinal Studies, Male, Middle Aged, Narcotic Antagonists, Opioid dependence, Opioid-Related Disorders, Treatment Outcome

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/25490610

Export Citation:

RIS Format

Top